REFERENCES
- Lee RG, Foester J, Lukens J, Paraskevas F, Greer JP, Rodger GM. Wintrobe's Clinical Hematology10. Canada: Lippincott Williams & Wilkins. 1999; 1: 1407–1435
- Srivatsa A, Arivatsa A. Assessment of adrenal endocrine function in Asian thalassemics. Indian Pediatr 2005; 42: 31–35
- Al-Elq AH, Al-Saeed HH. Endocrinopathies in patients with thalassemias. Saudi Med J 2004; 25: 1347–1351, [Review]
- Karamifar H, Shahriari M, Sadjadian N. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran. East Mediterr Health J 2003; 9: 55–60
- Zervas A, Katopodi A, Protonotariou A, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid 2002; 12: 151–154
- Aydinok Y, Darcan S, Polat A, et al. Endocrine complications in patients with beta-thalassemia major. J Trop Pediatr 2002; 48: 50–54
- Tiosano D, Hochberg Z. Endocrine complications of thalassemia. J Endocrinol Invest 2001; 24: 716–723, [Review]
- Kattamis AC, Antoniadis M, Manoli I, Kitra V, Petropoulos D, Grafakos S. Endocrine problems in ex-thalassemic patients. Transfus Sci 2000; 23: 251–252
- Zeitler PS, Travers S, Kappy MS. Advances in the recognition and treatment of endocrine complications in children with chronic illness. Adv Pediatr 1999; 46: 101–149, [Review]
- Mohammadian S, Bazrafshan HR, Sadeghi-Nejad A. Endocrine gland abnormalities in thalassemia major: a brief review. J Pediatr Endocrinol Metab 2003; 16: 957–964, [Review]
- Karagiorga-Lagana M. Fertility in thalassemia: the Greek experience. J Pediatr Endocrinol Metab 1998; 11(Suppl 3)945–951
- De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res 2002; 58(Suppl 1)72–79, [Review]
- De Sanctis V, Tangerini A, Testa MR, et al. Final height and endocrine function in thalassaemia intermedia. J Pediatr Endocrinol Metab 1998; 11(Suppl 3)965–971
- Raiola G, Galati MC, De Sanctis V, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab 2003; 16(Suppl 2)259–266, [Review]
- Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab 2000; 13: 651–656
- Lanzkowsky PH. Manual of Pediatric Hematology and Ooncology. 3. New York: Academic Press. 2000; 182–193
- Shamshirsaz A, Bakheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003; 3: 40
- Marshall W, Tanner J. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291
- Marshall W, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13
- Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999; 104: 936
- Biro FM, McMahon RP, Striegel-Moore R, et al. Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 2001; 138: 636
- Garn SM, LaVelle M, Rosenberg KR, Hawthorne VM. Maturational timing as a factor in female fatness and obesity. Am J Clin Nutr 1986; 43: 879
- Abbassi V. Growth and normal puberty. Pediatrics 1998; 102: 507
- Fung EB, Harmatz PR, Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol 2006; 135: 574
- Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. Br J Haematol 2006; 134: 438
- Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Clin Endocrinol (Oxf) 1995; 42: 581